In a woman undergoing frozen‑embryo transfer IVF, how should estradiol be administered (dose, route, and timing) to minimize miscarriage risk and affect spontaneous preterm birth, and when should it be discontinued during pregnancy?

Estradiol Administration in Frozen Embryo Transfer IVF

For frozen embryo transfer cycles, use transdermal estradiol at 100-200 mcg/day (or oral estradiol 2-4 mg/day if transdermal unavailable), starting on cycle day 1 and continuing until 6 weeks gestational age when fetal heartbeat is confirmed, at which point estradiol can be safely discontinued while continuing progesterone until 12 weeks.

Route Selection

Transdermal estradiol is the preferred route for FET endometrial preparation based on multiple considerations:

• Lower miscarriage rates: Transdermal administration shows significantly lower spontaneous abortion rates (23.0%) compared to oral estradiol (37.2%) 1
• Better pregnancy outcomes: Transdermal estrogen (Oestrogel) demonstrates significantly higher ongoing pregnancy and live birth rates compared to oral estradiol valerate 2
• Safer hormone profiles: Transdermal routes avoid first-pass hepatic metabolism and achieve more physiologic estrone/estradiol ratios 3

Dosing Strategy

Initial Dosing

Start with transdermal patches delivering 100-200 mcg/day or oral micronized estradiol 2-4 mg/day 4. If using oral estradiol, the typical starting dose is 1-2 mg daily, adjusted to control symptoms 5.

Constant vs. Increasing Dose

Use a constant dose regimen rather than an increasing dose protocol. The constant dose approach shows:

• Lower spontaneous abortion rates (23.0% vs 37.2%, P=0.041) 1
• Simpler administration with equivalent clinical pregnancy and live birth rates 1
• No advantage to mimicking natural cycle estradiol fluctuations

Target Serum Levels

Avoid excessively high estradiol levels (≥313 pg/mL or ≥528 pg/mL) on the day of progesterone initiation:

• Levels ≥313 pg/mL associate with 1.5-fold increased early miscarriage risk (adjusted OR 1.5,95% CI 1.06-2.18) 6
• Highest quartile levels (mean 528 pg/mL) show reduced implantation (RR 0.66), ongoing pregnancy (RR 0.66), and live birth rates (RR 0.70) 7
• Target range: 122-312 pg/mL on day of progesterone start for optimal outcomes 6

Timing and Duration

When to Start

Begin estradiol on cycle day 1 and continue until endometrial thickness reaches ≥8mm before initiating progesterone 2.

When to Discontinue

Discontinue estradiol at 6 weeks gestational age after confirming fetal heartbeat:

• Early discontinuation (at 6 weeks) shows significantly lower miscarriage rates (3.13%) compared to continuing until 12 weeks (18.75%, P<0.05) 8
• All patients who discontinued early and had confirmed heartbeat achieved live births (29/29) 8
• Continue progesterone supplementation until 12 weeks regardless of estradiol discontinuation 8

Critical Caveats

Programmed Cycles and Pregnancy Complications

Be aware that programmed cycles (PC) using exogenous estradiol show concerning obstetric outcomes:

• Higher birth weights (mean difference +292 grams) 9
• Increased postpartum hemorrhage risk (55% vs 25% in modified natural cycles, P=0.01) 9
• Elevated estradiol and progesterone levels persist into early pregnancy 9

These risks support early estradiol discontinuation once placental production is established.

Monitoring Requirements

• Measure serum estradiol on day of progesterone initiation to ensure levels are in optimal range (122-312 pg/mL) 6
• Confirm endometrial thickness ≥8mm before embryo transfer 2
• Perform ultrasound at 6 weeks to confirm gestational sac and fetal heartbeat before discontinuing estradiol 8

Progestogen Co-Administration

Always co-administer progestogen when prescribing estrogen to women with a uterus to reduce endometrial cancer risk 5. Continue progesterone supplementation until 12 weeks gestational age even after discontinuing estradiol 8.